Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Establishing the prevalence of non-classical congenital adrenal hyperplasia using serum 21-deoxycortisol concentrations — K De (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Establishing the prevalence of non-classical congenital adrenal hyperplasia using serum 21-deoxycortisol concentrations
Shared by
Frits R. Rosendaal
Establishing the prevalence of non-classical congenital adrenal hyperplasia using serum 21-deoxycortisol concentrations
Endocrine Abstracts
Article
2025
English
Authors
+5 more
KD
K De
MD
Mutsert Renee de
RN
Raymond Noordam
Abstract
1 min read
No abstract is provided for this article.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications
Evangelia Charmandari
,
Martina Weise
,
Stefan R. Bornstein
,
Graeme Eisenhofer
,
Margaret F. Keil
,
George Chrousos
,
Deborah P. Merke
Article
2002
Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Deborah P. Merke
,
Stefan R. Bornstein
,
Nilo A. Avila
,
George Chrousos
Article
1981
Late onset 21-hydroxylase deficiency is a genetic variant of the classic form of congenital adrenal hyperplasia (CAH)
George Chrousos
,
Gordon B. Cutler
,
David G. Mann
,
D. Lynn Loriaux
Article
2006
Metabolic Syndrome Manifestations in Classic Congenital Adrenal Hyperplasia
Evangelia Charmandari
,
George Chrousos
Article
2013
The association of serum glucose and insulin concentrations with hand osteoarthritis: the NEO study
Annemieke Visser
,
Martin den Heijer
,
W. Spoelman
,
Frits R. Rosendaal
,
T. Huizinga
,
M. Kloppenburg
Osteoarthritis and Cartilage
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.